Latest Chronic kidney disease Stories

NxStage Joins Home Dialyzors United Conference to Drive More Awareness of Home Hemodialysis

2012-10-08 15:22:51

LAWRENCE, Mass., Oct. 8, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Founder and Chief Executive Officer of NxStage, accepted Home Dialyzors United's (HDU) Trailblazer Award for NxStage's outstanding achievement in the innovation and advancement of home hemodialysis with the NxStage System One(TM), at the HDU's 3(rd) Annual Meet Up and Conference in Baltimore, MD. In...

NxStage Applauds Journal Article Urging Greater Use of Home Hemodialysis and Removal of Barriers that Deny Patients Access to Life-Altering Treatment Option

2012-10-05 10:21:42

LAWRENCE, Mass., Oct. 5, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today commented on a review article published on October 4 in the Clinical Journal of the American Society of Nephrology (CJASN) in which leading nephrologists advocate for broadened access to home hemodialysis based on its proven benefits and successful use by thousands of patients. Within the paper, "How to Overcome Barriers and Establish a...

New Home Hemodialysis Systems Easier To Use For Patients

2012-10-05 14:40:14

Highlights: -Home hemodialysis could allow patients to enjoy increased freedom, quality of life, greater ability to travel, and tangible health improvements. -Increased physician and patient education can eliminate barriers to home hemodialysis and increase its use. Approximately 2 million patients in the world receive some sort of dialysis treatment. Most patients with chronic kidney disease who undergo hemodialysis put up with a grueling treatment regimen that involves going into...

American Kidney Fund's Fourth Annual Gala, "The Hope Affair" Brings The Renal Community Together On October 17, 2012

2012-09-27 02:27:52

Event Honors Patients and Caregivers, Celebrating the People Who Inspire Us in the Fight Against Kidney Disease WASHINGTON, Sept. 27, 2012 /PRNewswire-USNewswire/ -- The American Kidney Fund's fourth annual national gala, The Hope Affair, will take place Wednesday, October 17, 2012, at 6:30 p.m. at the Andrew W. Mellon Auditorium in Washington, D.C. The event, themed "All Things Are Possible," will honor three remarkable individuals: a dialysis patient, a caregiver and the American...

Chronic Kidney Disease A Warning Sign Independent Of Hypertension Or Diabetes

2012-09-27 00:03:48

Two new studies from the Johns Hopkins Bloomberg School of Public Health and the Chronic Kidney Disease Prognosis Consortium found that the presence of chronic kidney disease itself can be a strong indicator of the risk of death and end-stage renal disease (ESRD) even in patients without hypertension or diabetes. Both hypertension and diabetes are common conditions with chronic kidney disease with hypertension being the most prevalent. The studies were released online in advance of...

Children With Kidney Disease Have Abnormal Carotid Arteries

2012-09-20 16:48:42

Striking findings highlight need for aggressive monitoring, early treatment to prevent later heart attacks, strokes A federally funded study led by researchers at Johns Hopkins Children's Center has found that children with mild to moderate kidney disease have abnormally thick neck arteries, a condition known as carotid atherosclerosis, usually seen in older adults with a long history of elevated cholesterol and untreated hypertension. The findings — published online ahead of print on...

Cytochroma Initiates Phase 3 Study of CTAP101 Capsules in Chronic Kidney Disease Patients

2012-09-20 02:29:59

MARKHAM, ON, Sept. 20, 2012 /PRNewswire/ - Cytochroma today announced the initiation of a phase 3 study of CTAP101 capsules ("CTAP101 Capsules") in patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency. The newly initiated trial is the first of two identical randomized, double-blind, placebo controlled, multi-site studies intended to establish the safety and efficacy of CTAP101 Capsules as a new treatment for SHPT...

University of Southern California and University Kidney Research Organization join to establish kidney research center at Keck School of Medicine of USC

2012-09-19 14:21:16

Singer and kidney transplant patient Natalie Cole applauds "brilliant" partnership of USC and UKRO LOS ANGELES, Sept. 19, 2012 /PRNewswire-USNewswire/ -- The Keck School of Medicine of the University of Southern California (USC) and the University Kidney Research Organization (UKRO), a Los Angeles-based non-profit group that supports medical research concerning the causes, improved treatments for, and the prevention of kidney disease, announced today that they have joined together to...

Abaxis Announces the Launch of Kidney Profile Plus Panel

2012-09-18 02:27:29

UNION CITY, Calif., Sept. 18, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point of care instruments and consumables for the medical, research, and veterinary markets, and providing reference lab services to the veterinary and research markets, announced today the launch of the VetScan Kidney Profile Plus Rotor exclusively for use on the VetScan VS2 Chemistry instrument. The new KPP rotor contains all critical chemistry analytes needed...

Treatment, Quality Of Life Of Late-Stage Chronic Kidney Disease

2012-09-12 10:55:26

Renal transplantation is best treatment option for improving quality of life in people with late-stage chronic kidney disease In people with late-stage chronic kidney disease, renal transplantation is the best treatment option to improve quality of life, but for those receiving dialysis, home-based automated peritoneal dialysis (in which fluids are infused into the abdominal cavity and can be done nightly at home) provides a better quality of life than continuous ambulatory peritoneal...